MergerJun 16, 2026, 04:07 PM
Esperion Therapeutics Merger HSR Waiting Period Expires
AI Summary
Esperion Therapeutics announced that the Hart-Scott-Rodino Antitrust Improvements Act waiting period for its merger with Essence Parent Inc. expired on June 15, 2026. This marks a key step towards completing the acquisition, which was initially disclosed on May 1, 2026. The merger remains subject to other customary closing conditions, including approval by Esperion's stockholders at a special meeting scheduled for July 8, 2026.
Key Highlights
- Merger Agreement with Essence Parent Inc. was entered on May 1, 2026.
- Hart-Scott-Rodino (HSR) waiting period for the merger expired on June 15, 2026.
- Merger completion remains subject to customary closing conditions.
- Special stockholder meeting to adopt the Merger Agreement is scheduled for July 8, 2026.
Price Impact
More from ESPR